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I. INTRODUCTION
A sweetener with many names — Indian muscovado, Mexican
piloncillo, African and Asian jaggery, and Colombian panela — this
unrefined, non-centrifugal cane sugar has been a staple product across the
world for centuries.1 No country’s constituents appreciate this delicacy

* Associate Member, UNIVERSITY OF CINCINNATI LAW REVIEW
1. J. Kenji López-Alt, Making Panela at a Colombian Sugar Mill is Still a Low-Tech Affair,
SERIOUS EATS (Aug. 10, 2018), https://www.seriouseats.com/2015/01/making-panela-colombian-sugarmill-low-tech.html.
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more than those of Colombia.2 Colombia is the runner-up in global panela
production and the world leader in panela consumption per capita.3 On
average, each Colombian citizen consumes over seventy pounds of panela
each year.4 Beyond its use in cakes, pastries, and coffees, Colombians
dissolve panela in hot water to create aguapanela.5 Served hot or cold,
often with lime, aguapanela is a significant source of calories for working
Colombians.6 Additionally, aguapanela mixed with ginger is used for
medicinal purposes because of the purported health benefits of its trace
vitamins and minerals, which are byproducts of panela’s crude production
method.7
In 2020, the United States Patent and Trademark Office (the “USPTO”)
issued U.S. Patent No. 10,632,167 (“the ‘167 Patent”) for producing
policosanol-rich sugarcane juice, which looks to capitalize on panela’s
purported health benefits.8 To produce that juice, the ‘167 Patent
describes a production method that closely resembles traditional methods
used to make panela.9 Because patents grant their owners exclusionary
rights over the practices claimed by the patent, Colombian panela
producers are concerned that the ‘167 patent will upend their way of life.10
This Comment analyzes the validity of the ‘167 patent and its potential
impact on the Colombian panela industry. Part II provides an overview of
the Colombian panela industry, the U.S. patent law system, relevant
Colombian law, and the ‘167 Patent. Although Colombian patent law is
discussed, this Comment primarily focuses on the U.S. patent law system.
Part III discusses why the ‘167 Patent would likely be upheld if its validity
was challenged in a court of law and, if upheld, why the ‘167 Patent may
not affect Colombian panela producers. Finally, Part IV emphasizes the
limits of the patent system and the importance of having a sound scientific
basis when filing an application for patent.
II. BACKGROUND
Patent litigation is one of the most expensive types of litigation because

2. Id.
3. Id.
4. Kirsten Begg, Aguapanela: The Truth, COLOMBIA REPS. (Mar. 12, 2009),
https://colombiareports.com/aguapanela/.
5. Jennie Erin Smith, Colombians Ask: Who Would Dare Patent Panela?, N.Y. TIMES (Jan. 26,
2021), https://www.nytimes.com/2021/01/26/science/colombia-panela-patent-gonzalez.html.
6. Id.
7. Id.
8. Id.
9. Id.
10. Id.
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there are so many layers to each case.11 The current issue is no exception.
Determining whether Colombian panela production would infringe the
‘167 Patent requires analysis of Colombian panela’s deep-rooted,
traditional method of production as well as the intricacies of U.S. patent
law and overlapping international and foreign law. First, Section A of this
Part discusses panela’s significance to Colombians and its traditional
method of production. Second, Section B provides a brief overview of the
U.S. patent system. Third, Section C summarizes Colombian patent law
and other Colombian laws relevant to panela production. Finally, Section
D walks through the ‘167 Patent and its controversial scientific
foundations.
A. The Significance and Production of Panela
Panela is more than a diet staple to Colombians; it’s an irreplaceable
source of income.12 The panela industry makes up nearly twelve percent
of the Colombian workforce and is one of the main sources of income for
more than 70,000 Colombian families.13 Through both its direct and
indirect impact, the panela industry affects 350,000 Colombians and
accounts for approximately 6.7% of Colombia’s agricultural gross
domestic product.14 Further, it is estimated that over 98% of Colombian
panela is consumed domestically, with only around 0.4% exported and
the remaining used as input for industrial processes.15
The process of making panela has gone essentially unchanged since
sugarcane was first brought to South America in the sixteenth century.16
That process begins in one of the over 200,000 hectares of Colombian
sugarcane fields.17 Couriers, or cutters, chop down mature sugar cane
stalks by hand.18 A carguero19 then stacks the chopped stalks onto the
backs of donkeys and mules and accompanies it back to the trapiche20
11. JANICE M. MUELLER, PATENT LAW 30 (Rachel E. Barkow et al. eds., 6th ed. 2020).
12. Gonzalo Rodriguez et al., Panela Production as a Strategy for Diversifying Incomes in Rural
Area of Latin America, FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS [FAO]
(2007), https://www.fao.org/3/ap307e/ap307e.pdf.
13. Id.
14. Id.
15. Id.
16. Dennis Bejarano, Panela’s Bitter Future, SLOW FOOD (July 23, 2015),
https://www.slowfood.com/panelas-bitter-future.
17. Begg, supra note 4.
18. Smith, supra note 5.
19. A carguero, or freighter, is an “operator who lifts and accompanies the sugarcane in the
transport, which takes it from the batch to the sugar mill, generally it is done on the mules and the sugar
cane from the sugar mill to the loading point.” Carguero, PANELERO INFO. SYS. (Apr. 2, 2019),
http://www.sipa.org.co/wp/index.php/glossary/carguero/.
20. A trapiche is the place “where sugarcane is processed to turn it into honey or panela.” Trapiche
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where the panela is made.21 Most trapiches build a stockpile of chopped
stalks for two weeks while workers are hired.22
First, the raw sugarcane stalks are processed through hand and waterpowered mechanical rollers which grind those stalks into a juice.23 These
hand and water powered rollers are a departure from using mules to power
the rollers, a historic practice banned by the Colombian government for
sanitation purposes.24 Next, the juice from the sugarcane stalks streams
down into a series of large heated pans.25 The pans are heated by a furnace
fueled with bagasse, the dried carcasses of grinded stalks.26 As the raw
sugarcane juice is heated, workers add a wood pulp to the liquid to
separate impurities from the juice.27 Once the juice begins to boil, workers
use massive ladles to skim the surface of the juice and then transfer it to
a heating vessel.28 With each transition, the sugarcane juice reduces,
ferments, thickens, and darkens.29 There is no scientific determination
that the sugar has been sufficiently heated or reached the appropriate
sugar density; a worker may dip a stick in the heated syrup and cool it in
cold water or check it with a wet, bare hand.30
The final steps for processing the juice vary from trapiche to trapiche
depending on the final product. In one method, the hot syrup-like solution
is poured into molds and left to cool and harden.31 Common mold shapes
include rectangular blocks and cones.32 Another method produces a pattyshaped product. After transferring the thickened, nearly crystalized syrup
to a final surface, workers begin to stir the product vigorously for
cooling.33 A pesador34 then packs the cooling sugar into evenly sized
patties. Once the patties fully cool, they begin to harden and are often
stamped with the label for eventual sale.35

panelero, PANELERO INFO. SYS. (Mar. 20, 2019), http://www.sipa.org.co/wp/index.php/glossary/trapichepanelero/.
21. Smith, supra note 5.
22. Id.
23. Id.
24. Lopez-Alt, supra note 1
25. Id.
26. Id.
27. Smith, supra note 5.
28. Id.
29. Lopez-Alt, supra note 1.
30. Smith, supra note 5.
31. Gaston Rings, Process of making panela, trapiche in Colombia, YOUTUBE (Aug. 24, 2009),
https://www.youtube.com/watch?v=1K6XKadWWq8.
32. Smith, supra note 5.
33. Lopez-Alt, supra note 1.
34. Pesadors are trapiche workers that hand-weigh and shape hot panela into portions at the end
of production. Smith, supra note 5.
35. Lopez-Alt, supra note 1.
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Because these trapiches provide so many jobs for Colombians,
Colombia issued Law 40 of 1990 (“Law 40”) to regulate the production
and exportation of panela.36 First, Law 40 outlawed large sugar
corporations from producing panela in Colombia by limiting panela
establishments to a grinding capacity of ten tons per hour.37 Second, Law
40 allowed the government to regulate the conditions and quantities in
which panela is produced.38 Additionally, Law 40 required that
commercial panela producers register with the government and all
exported panela be government-approved to guarantee the quality of the
product.39 Lastly, Law 40 set out specific production, health, and quality
standards that all panela must meet.40
Despite some mechanical improvements to panela production, most
trapiches operate a very traditional operation.41 Although some producers
have been able to purchase upgrades like automobiles for sugarcane
transport, high efficiency cane rollers, or closed tanks for evaporation,
such machines are too expensive for most trapiche owners.42 Regardless,
the ‘167 Patent may jeopardize both traditional and industrial panela
producers.43 Because the process for producing panela, industrialized or
not, consists of the same fundamental steps, the exclusionary rights
granted by the ‘167 Patent could spell out disaster for Colombian panela
producers.44
B. Introduction to United States Patent Law
Before an analysis can be done on the potential impact and viability of
the ‘167 Patent, a basic understanding of U.S. patent law is necessary.45
The following Subsections overview patents generally, the major tenants
of patentability applied by the USPTO and U.S. courts, and the judicial
approach to assessing patent infringement.

36. L. 40, diciembre 4, 1990, DIARIO OFICIAL [D.O.] (Colom.) [hereinafter Law 40].
37. Id.
38. Id.
39. Id. “It will be understood that the panelero establishment is of a commercial nature when its
production exceeds the amount of one tonne per week” Id.
40. Id.
41. Lopez-Atl, supra note 1.
42. Id.;
Alcaldia
Obando,
BIOBANDO,
YOUTUBE
(Sept.
8,
2012),
https://www.youtube.com/watch?v=LYQlV4htOdg.
43. Smith, supra note 5.
44. Id.
45. This is not intended to be a comprehensive guide to U.S. patent law. Only a basic overview
of the major tenants of patentability is provided.
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1. Patent Overview
Patents are a form of intellectual property geared towards scientific
discoveries, inventions, and processes.46 Like copyrights, trademarks, and
trade secrets, patents confer certain intangible rights to their owners.47
These rights are secured by the Patent and Copyright Clause of Article I
of the U.S. Constitution, which states that “[t]he Congress shall have
Power…[t]o promote the Progress of Science and useful Arts, by securing
for limited Times to Authors and Inventors the exclusive Right to their
respective Writings and Discoveries.”48 In other words, the Patent and
Copyright Clause implies exclusionary rights to inventors and authors to
incentivize innovation and creativity.49
The exclusionary rights that accompany an issued patent allow the
patent’s owner to prevent others from making, using, offering to sell,
selling, or importing that patented invention throughout or into the United
States.50 By offering avenues for protection and exclusivity for their
works, innovators are financially motivated to create.51 The government
only offers these exclusionary rights for a limited time and requires full
disclosure of the invention at the time of application for patent.52 The
government limits exclusionary rights to ensure the public benefits from
the disclosure of new technologies even if the inventor decides not to put
their invention on the market.53 Once a patent’s limited window of
protection expires, the public is free to make, use, sell, and import the
expired patent’s claimed invention or method.54 Further, patents and
patent applications are published and made available to the public,
ensuring the dissemination of their knowledge and fueling future
innovation.55
2. Statutory Patentability Requirements
Before inventors are granted exclusivity rights in the U.S. over their

46. MUELLER, supra note 11, at 8.
47. Id.
48. U.S. Const. art I, § 8, cl. 8.
49. Id.
50. 35 U.S.C. § 271(a) (2012).
51. MUELLER, supra note 11, at 31.
52. Id. A newly issued U.S. patent is valid for at least twenty years from the date of its earliest
effective filing date in the U.S. Patent and Trademark Office. Applications that face undue delay in their
prosecution process might qualify to have their terms extended. 35 U.S.C. § 154 (2019).
53. MUELLER, supra note 11, at 31.
54. Id.
55. Id. at 73-76.
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invention, they must file a patent application with the USPTO.56 Patent
applications must fully disclose the invention such that someone having
ordinary skill in the art would be able to use the claimed invention.57 Once
prepared and filed, the application goes through a process called patent
prosecution where the USPTO evaluates the application and determines
whether the invention is patentable.58 The determination of patentability
revolves around three main requirements: (1) utility; (2) novelty; and (3)
non-obviousness.59
The first requirement of patentability is utility.60 For an invention to be
useful, or have utility, it need only cross a very low threshold.61 If the
invention is “capable of providing some identifiable benefit,” then it is
useful under the law.62 Despite that low bar, utility is still necessary. For
example, in Brenner v. Manson, the United States Supreme Court
considered a chemist’s patent application for a steroid that claimed to
have tumor-inhibiting effects in mice.63 However, the applicant based
these claims entirely on the steroid’s similar make-up to another
compound which had actually demonstrated tumor inhibiting effects.64
The Court agreed with the USPTO and rejected the chemist’s patent
application for lack of utility, holding that being similar to a separate
useful invention does not prove utility.65 For the government to grant
exclusivity rights, an inventor must disclose a legitimate use for his
invention, not merely allude to some potential use for someone else to
discover.66 Additionally, Brenner laid the ground work for the “specific,
substantial, and credible” standard of patent utility.67 Patent examiners are
told not to impose utility rejections “if the applicant has asserted that the
claimed invention is useful for any particular practical purpose (i.e., it has
a ‘specific and substantial utility’) and the assertion would be considered
credible by a person of ordinary skill in the art.”68

56. Id. at 12.
57. 35 U.S.C. § 112(a) (2019).
58. MUELLER, supra note 11, at 66.
59. MUELLER, supra note 11, at 67.
60. 35 U.S.C. § 101(a) (2019).
61. Juicy Whip, Inc. v. Orange Bang, Inc., 185 F.3d 1364, 1366 (Fed. Cir. 1999).
62. Id.
63. 383 U.S. 519, 522 (1966).
64. Id.
65. Id. at 535.
66. Id. This also leans towards another factor, enablement, that is not an issue here regarding
panela. 35 U.S.C. § 112(a) (2019).
67. Brenner, 383 U.S. at 534-535.
68. MPEP (9th ed., June 2020) § 2107(II)(A)(3). “Credibility is assessed from the perspective of
one of ordinary skill in the art in view of the disclosure and any other evidence of record (e.g., test data,
affidavits or declarations from experts in the art, patents or printed publications) that is probative of

Published by University of Cincinnati College of Law Scholarship and Publications,

7

University of Cincinnati Law Review, Vol. 90, Iss. 2 [], Art. 8

672

UNIVERSITY OF CINCINNATI LAW REVIEW

[VOL. 90

The second requirement for patentability is novelty.69 The LeahySmith America Invents Act of 2011 simplified the basic principles of
novelty: if a claimed invention has been “patented, described in a printed
publication, or in public use, on sale, or otherwise available to the public
before the effective filing date of the claimed invention” anywhere in the
world, then the claimed invention is considered to be anticipated and
therefore not patentable.70 Further, for an invention to be anticipated, it
must be described in its entirety by the earlier filed patent, patent
application, or printed publication (collectively, “prior art”); this is known
as the strict identity standard.71 For example, in Titanium Metals Corp. v.
Banner, employees of Titanium Metals Corporation of America
(“Titanium”) developed a titanium alloy and received a patent on the
invention.72 The patent claimed a “titanium [(Ti)] base alloy consisting
essentially by weight of about 0.6% to 0.9% nickel [(Ni)], 0.2% to 0.4%
molybdenum [(Mo)], up to 0.2% maximum iron, balance titanium.”73
Five years earlier, however, an article had been published in a Russian
journal featuring a data point corresponding to a Ti-Ni-Mo alloy
consisting of 0.75% Ni and 0.25% Mo.74 When the Titanium patent’s
validity was challenged, the United States Court of Appeals for the
Federal Circuit held that the patent was wrongly issued because it was
anticipated by the alloy disclosed in the Russian journal article and
therefore unpatentable for lack of novelty.75 Alternatively, if the alloy
disclosed in the Russian journal article instead comprised of only 0.4%
Ni or 0.5% Mo, Titanium’s alloy would not have satisfied the strict
identity standard and would have qualified as novel over the previously
disclosed alloy.76
The third requirement for patentability is non-obviousness.77 Nonobviousness bars an invention from being a mere variation or combination
of prior art that “would have been obvious to a person having ordinary
skill in the art” (“PHOSITA”).78 PHOSITAs are afforded a certain degree
of creativity within their fields; as a result, the USPTO commonly rejects
the applicant’s assertions. An applicant need only provide one credible assertion of specific and
substantial utility for each claimed invention to satisfy the utility requirement.” Id. § 2107(II)(B)(1)(ii).
69. MUELLER, supra note 11, at 67.
70. 35 U.S.C. § 102(a) (2019).
71. MUELLER, supra note 11, at 242.
72. 778 F.2d 775, 776 (Fed. Cir. 1985).
73. Id.
74. Id.
75. Id. at 782. The “up to 0.2% maximum iron” limitation in Titanium’s claim is interpreted as
including 0% iron. Thus, the strict identity standard was satisfied even though the Russian alloy did not
include iron. Id.
76. Id. at 781.
77. MUELLER, supra note 11, at 67.
78. 35 U.S.C. § 103 (2019).
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the following for being obvious: (1) combinations of analogous prior art;
(2) substitutions of elements in a piece of prior art; and (3) situations in
which there are only a limited number of possible solutions to a
problem.79 The following is a classic example of obviousness:80
A is known in the prior art, and B is known in the prior art. Upon looking
at A and then looking at B, would [a PHOSITA] consider A+B to be
already known? If the answer is yes, then A+B is obvious. If the answer is
no, then A+B is not obvious.81

A fourth and less common requirement for patentability is that a patent
applicant may only be granted a single U.S. patent on a given invention.82
This requirement only pertains to inventors with at least one other pending
U.S. application or granted U.S. patent.83 If a patent applicant attempts to
receive a second patent over his already patented invention, the USPTO
will issue a “double patenting” rejection.84
There are two types of double patenting rejections.85 First, a same
invention-type double patenting rejection is when a later-filed application
claims the exact same scope as the applicant’s original patent or
application.86 Second, an obviousness-type double patenting rejection
exists when the later-filed application claims “a merely obvious variant”
of the applicant’s original patent or application.87 Double patenting
rejections are issued by the USPTO and U.S. courts to prevent parties
from unjustifiably extending monopolies over already-patented products
or processes.88 Applicants often attempt to circumvent the “one patent per
invention” rule by obtaining patents on products used to produce the
already patented invention or by obtaining patents on new uses,
formulations, or preparations of the invention.89
3. Patent Infringement
As mentioned above, a patent grants its owner the right to exclude

79. KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398, 400-403 (2007).
80. Gene Quinn, Patentability: The Nonobviousness Requirement of 35 U.S.C. 103, IP
WATCHDOG (June 17, 2017), https://www.ipwatchdog.com/2017/06/17/patentability-nonobviousness35-usc-103/id=84716/.
81. Id.
82. MUELLER, supra note 11, at 82.
83. Id.
84. Id.
85. Id.
86. Id.
87. Id.
88. Id. at 83.
89. Id. at 82 n. 264.
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others from making, selling, using, or importing the patented invention.90
When a person violates those rights, it is called patent infringement. 91 A
person can either infringe literally or under the doctrine of equivalents.92
Literal infringement is when a defendant’s actions fall directly within the
bounds of a patent’s claims.93 For example, in Titanium Metals Corp. v.
Banner, Titanium’s patent was anticipated by the Ti-Ni-Mo alloy
(containing 0.75% Ni and 0.25% Mo) disclosed in the Russian journal
article.94 If the article had never been published and Titanium’s patent
issued, a competitor who subsequently produced the disclosed alloy
would be held liable for literal infringement because the produced alloy
would fall squarely within the ranges claimed by Titanium’s patent.95 To
illustrate further, if in that same scenario the competitor’s alloy had
comprised only 0.59% Ni and 0.41% Mo, then the competitor would not
be held liable for literal infringement.96 The common law doctrine of
equivalents addresses this loophole.97
The doctrine of equivalents asks whether potential infringers’ actions
“perform substantially the same function, in substantially the same way,
to achieve the same result”; if so, then there is infringement.98 This is a
fact-specific and unreliable inquiry.99 For example, if Titanium’s
hypothetical competitor had produced the Ti-Ni-Mo alloy comprised of
0.59% Ni and 0.41% Mo, then a court would have to determine whether
the 0.01% composition changes would produce a substantially similar
alloy.100 If the alloy satisfied the substantial similarity test, it would have
been found to infringe under the doctrine of equivalents.101 But, if the
0.01% composition changes had significantly altered a characteristic,
such as the alloy’s conductivity or tensile strength, then it would have
been unlikely to infringe under the doctrine of equivalents.102
An accused patent infringer can generally raise two arguments to avoid
penalty: (1) claim that the patent is actually invalid and should never have

90. Id. at 735.
91. 35 U.S.C. § 271(a) (2019).
92. MUELLER, supra note 11, at 735.
93. Id. at 782.
94. 778 F.2d 775, 776 (Fed. Cir. 1985).
95. Id.
96. MUELLER, supra note 11, at 782. The ranges of the original Titanium patent were 0.6-0.9%
Ni, 0.2-0.4% Mo, up to 0.2% Fe, balance Ti. Titanium Metals Corp. v. Banner, 778 F.2d at 776.
97. Id. at 783
98. Graver Tank & Mfg. Co. v. Linde Air Prod. Co., 339 U.S. 605, 608 (1950).
99. MUELLER, supra note 11, at 787.
100. Graver Tank & Mfg. Co. v. Linde Air Prod. Co., 339 U.S. at 608.
101. Id.
102. Id.
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been issued; or (2) claim that they did not actually infringe.103 Claiming
invalidity forces the court to reevaluate the patent with regard to the
requirements of patentability.104 When the court reevaluates the validity
of an issued patent, the defendant must overcome the patent’s
presumption of validity.105
A defendant claiming that it did not actually infringe argues that its
actions fall outside of the scope of the patent’s claims.106 Here, the court
must interpret the scope of those claims and determine what the patent
protects.107 Once the court has interpreted the patent, it determines
whether the defendant’s actions fall within the scope of the claims.108 If
the court finds that the defendant’s actions fall within the scope of the
claims either literally or under the doctrine of equivalents, then there is
infringement.109
Alternatively, a defendant that has been performing the allegedly
infringing activity since before the public disclosure of the issued patent
may avail a third defense.110 Known as prior user rights, an accused
infringer may continue its allegedly infringing activity if: (1) “such
person, acting in good faith, commercially used the subject matter”; and
(2) “such commercial use occurred at least 1 year before the earlier of
either…the effective filing date of the claimed invention or the date on
which the claimed invention was disclosed to the public.”111 If the court
finds that these elements are satisfied, then the accused infringer will
prevail.112
C. Introduction to Colombian Patent Law
The Colombian patent system operates on slightly different terms than
its U.S. counterpart.113 Once a patent application is submitted to the
Colombian Patent Office (“Division de Nuevas Creaciones”), the
invention is evaluated for newness, inventive step, and industrial

103. MUELLER, supra note 11, at 853.
104. Id.
105. Id. at 959.
106. Id. at 750.
107. Id.
108. Id.
109. Id. at 735.
110. Id. at 860.
111. 35 U.S.C. § 273 (2015).
112. MUELLER, supra note 11, at 861-862.
113. Pamela Bechtel Hwang, Colombia: gateway to South America's Patent Prosecution Highway,
DLA PIPER (Dec. 10, 2012), https://www.dlapiper.com/en/us/insights/publications/2012/12/colombiagateway-to-south-americas-patent-prosec__/.
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applicability.114
First, similar to the novelty requirement under U.S. patent law, a
Colombian invention submitted for patent must be new and cannot have
been made previously available to the public.115 Public availability
includes any written or oral description, public use, sale, or offer for sale
of the invention prior to the application’s priority date.116 Also like U.S.
patent law’s novelty requirement, publicly disclosed information
regarding the Colombian patent application must satisfy the strict identity
standard, meaning prior art that does not describe the claimed invention
in full cannot destroy novelty.117
Second, similar to the non-obviousness requirement under U.S. patent
law, a Colombian invention submitted for patent must demonstrate an
inventive step.118 For an invention to be inventive in light of the prior art,
it cannot be deemed “obvious or evidently derived from the prior art by a
person ordinarily skilled in the art.”119 Further, inventive step is typically
assessed according to a problem-solution approach.120 Under both the
Colombian inventive step and U.S. non-obviousness standards, a patent
rejected as obvious can be rebutted because of secondary
considerations.121 Examples of secondary considerations include
evidence of surprising results, economic success, a longstanding hole in
the market, excessive experimentation, and prior art that teaches away
from what the invention claims.122
Third, similar to the utility requirement under U.S. law, a Colombian
invention submitted for patent must have industrial applicability, which
requires that the invention be capable of being “produced or used in any
type of industry.”123 The term “industry” is defined as “involving any
productive activity, including services.”124 The Colombian industrial
applicability requirement is therefore nearly interchangeable with the

114. U.S. COM. SERVICE, U.S. DEP’T COM., INTELLECTUAL PROPERTY RIGHTS TOOLKIT
COLOMBIA (2011).
115. CARLOS R. OLARTE ET AL., GETTING THE DEAL THROUGH – PATENTS 52 (Stuart J. Sinder
eds., 10th ed., 2013).
116. Id.
117. Id.
118. Id.
119. Id.
120. Id.
121. Id.
122. Id. “Teaching away” means that the piece of prior art suggests or requires an invention only
work in a way opposite or contrary to that of the newly claimed invention. Id.
123. Subregional Integration Agreement (Cartagena Agreement), Decision 486—Common
Provisions on Industrial Property art. 19, Sept. 14, 2000, available at: https://www.wipo.int/edocs/lexdocs/
laws/en/can/can012en.pdf [hereinafter Decision 486].
124. Id.
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U.S. utility requirement.125
Ownership of a Colombian patent gives the owner the right to prevent
third parties from manufacturing, selling, offering to sell, importing, and,
in the case of a method claim, using the patented invention.126 Under
Colombian law, for a party to infringe on a patent, it must do so
literally.127 Unlike the U.S., Colombia runs on a civil law system.128 Civil
law systems do not rely on case law; instead, courts lean heavily on
statutes, codes, treaties, and other types of written laws. 129 Because there
is no written doctrine of equivalents in Colombian patent law, a patent
owner cannot rely on the infringer’s actions being substantially similar to
its patent to prevail on an infringement claim.130 A patent owner’s success
in infringement actions therefore depends on whether courts interpret
patent claims broadly enough to find literal infringement.131
Prior user rights are also recognized in Colombia.132 A party qualifies
for Colombian prior user rights if the party “in good faith and before the
priority date or the filing date of the application on which the patent was
granted, was already using or exploiting the invention, or had already
made effective and serious preparations for such use or exploitation.”133
Unlike its U.S. counterpart, Colombian prior user rights are not limited to
those who practiced an issued patent more than one year prior to its
disclosure.134
D. The Claims and Prosecution History of Patent No. 10,632,167
On April 28, 2020, the ‘167 Patent was issued to Jorge Enrique
Gonzalez Ulloa (“Mr. Gonzalez”).135 The ‘167 Patent’s title, “System and
method for processing raw sugarcane maximizing the preservation of
policosanols during production of a shelf stable potable cholesterolreducing product,” is deceiving.136 At first glance, the patent merely
discloses a process for manufacturing a pharmaceutical, but a closer

125. FREDERICK M. ABBOTT ET AL., INTERNATIONAL INTELLECTUAL PROPERTY IN AN
INTEGRATED WORLD ECONOMY 218 (Rachel E. Barkow et al. eds. 4th ed. 2019).
126. Decision 486, supra note 123.
127. Olarte, supra note 115, at 51.
128. What is the Civil Law?, LSU LAW (last visited Apr. 17, 2021), https://www.law.lsu.edu
/clo/civil-law-online/what-is-the-civil-law/.
129. Id.
130. Olarte, supra note 115, at 51.
131. Id.
132. Decision 486, supra note 123.
133. Id.
134. Id.
135. U.S. Patent No. 10,632,167 (filed Nov. 3, 2017).
136. Id.
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examination reveals a strong resemblance to panela production.
The ‘167 Patent claims a process for producing a policosanol-rich
sugarcane juice product.137 Policosanol is an alcohol derived from the
waxy part of plants that the ‘167 Patent claims is “an effective remedy for
the treatment of unhealthy elevated blood cholesterol levels in
humans.”138 But, the studies that support these alleged benefits were
produced by a single research group whose results have since been
unrepeatable.139 Moreover, the ‘167 Patent faced double-patenting and
obviousness rejections during patent prosecution but was able to
overcome the rejections by emphasizing its policosanol-centered
disclosure.140 The following paragraphs explain policosanol and its
uncertain standing in the scientific community, describe the process
claimed by the ‘167 Patent, and breakdown the ‘167 Patent’s prosecution
history.
1. The Uncertainties of Policosanol
In the early 2000’s, a Cuban research group released its findings on the
therapeutic effects of a sugarcane wax-based policosanol supplement.141
The Cuban research group’s findings showed that the supplement was an
efficacious treatment for various cardiovascular-related ailments,
particularly hypercholesterolemia.142 The research group claimed that a
daily intake of the supplement lowered overall cholesterol levels by
increasing the liver’s ability to process low-density lipoproteins (“LDL”)
and decreasing HMG-CoA reductase activity.143 These findings were
significant because the prescription medications normally used to treat
high cholesterol can have harmful side effects.144 In contrast, the

137. Id.
138. Id.
139. Christopher P. F. Marinangeli et. al, Policosanols as Nutraceuticals: Fact or Fiction,
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, Mar. 2010, at 259.
140. U.S. Patent No. 10,632,167 (filed Nov. 3, 2017), Non-Final Office Action dated May 21, 2019,
p. 3, 5 [hereinafter Non-Final Office Action].
141. Marinangeli, supra note 139.
142. Id. “Despite low bioavailability, numerous studies originating in Cuba have shown PC
supplements to be efficacious treatments for various cardiovascular-related ailments including
hypercholesterolemia, poor arterial function, poor antioxidant status, and intermittent claudication.” Id. at
260.
143. Id. LDL is commonly referred to as “bad cholesterol” and HMG-CoA reductase inhibitors
make-up most common cholesterol lowering drugs. LDL and HDL Cholesterol: “Bad” and “Good”
Cholesterol, CENTERS FOR DISEASE CONTROL AND PREVENTION (Jan. 31, 2020),
https://www.cdc.gov/cholesterol/ldl_hdl.htm; Agam B. Bansal & Manouchkathe Cassagnol, HMG-CoA
Reductase Inhibitors, NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION (Nov. 4, 2020),
https://www.ncbi.nlm.nih.gov/books/NBK542212/.
144. Marinangeli, supra note 139, at 265.
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policosanol supplement presented zero adverse side effects.145
Despite the promise of a natural and side-effect-free method of
lowering cholesterol, the scientific community has met the Cuban studies
with skepticism.146 This skepticism grew as researchers were unable to
produce even mildly similar results to the original Cuban study.147
Researchers outside Cuba attempted to recreate the original experiments,
but not a single experiment showed significant changes in patients’
cholesterol levels.148 When the adverse findings were released, the
original Cuban researchers claimed that the policosanol used in their
study had “unique properties.”149 Interestingly, the Cuban group used a
sugarcane-based supplement, whereas the external research groups used
policosanols derived from plants other than sugarcane and prepared them
with different methods.150 Despite those differences, the policosanols
used by the external groups had purity levels and alcohol chain lengths
similar to those of the original Cuban policosanol supplement.151 Further,
the original Cuban supplement was later tested by a different research
group and it presented no signs of lowering cholesterol.152 Ultimately,
even though there are a number of studies that refute the results of the
original Cuban research group, more research must be conducted before
definitively stating that the original studies were falsified.153
2. The Claims of U.S. Patent No. 10,632,167
The ‘167 U.S. Patent claims a process of producing a policosanol-rich
sugarcane juice.154 Trademarked in the U.S. as “Policane,” the product is
intended to be a beverage for everyday consumption.155 Policane is
comparable to Colombian aguapanela and the processes for producing
them are nearly identical.156
The ‘167 Patent’s process begins with harvesting raw sugarcane by

145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
155.
156.

Id.
Id. at 259.
Id. at 260.
Id.
Id. at 260.
Id. at 262.
Id.
Id.
Id. at 265.
U.S. Patent No. 10,632,167 (filed Nov. 3, 2017).
Smith, supra note 5.
Id.
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hand.157 Next, the unwashed cane is chopped into small pieces.158 Then,
the chopped cane is softened with cool water and juiced in a series of
mechanical rollers at the lowest possible rate and a pressure of about
1,500 pounds per square inch.159 The policosanol-rich juice is collected
only from the first two rollers.160
This policosanol-rich juice is then filtered to remove larger unwanted
particles.161 Next, the pH and sugar density levels of the juice are managed
in a series of clarification, heating, and inversion steps. First, calcium
hydroxide is added to lower the pH level of the juice.162 Second, the juice
is heated to no more than seventy degrees Celsius to preserve the
policosanols.163 Flocculates are then added to the juice to collect
impurities.164 These sink to the bottom of the vats and are vacuumed
out.165 Bubbles are then pumped through the vat to push the flocculates to
the top of the vat where the impurities are skimmed off the top.166 Finally,
the juice is evaporated to increase its sugar density, the remaining syrup
is inverted with citric or phosphoric acid to reduce the pH, and a sugar
vacuum is used to once again increase the sugar density before it is left to
cool.167
3. The Prosecution History of U.S. Patent No. 10,632,167
Like most other patent applications, the ‘167 Patent’s application was
initially rejected by the USPTO and deemed unpatentable by an
examiner.168 Patent prosecution allows for an applicant to make changes
to an application or introduce arguments as to why the USPTO examiner
should not have rejected the application.169 The ‘167 Patent’s application
faced two rejections.170 The first rejection was an obviousness-type
double patenting rejection related to a separate patent owned by Mr.
Gonzalez, U.S. Patent No. 6,245,153 (“the ‘153 Patent”).171 The examiner
157. U.S. Patent No. 10,632,167 (filed Nov. 3, 2017). Mechanical harvesting of sugarcane
typically employs a burning mechanism which reduces policosanol levels. Id.
158. Id.
159. Id.
160. Id.
161. Id.
162. Id.
163. Id.
164. Id.
165. Id.
166. Id.
167. Id.
168. Non-Final Office Action, supra note 140.
169. MUELLER, supra note 11, at 68.
170. Non-Final Office Action, supra note 140.
171. Id. at 3.
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also rejected the ‘167 Patent’s application as obvious over the ‘153
Patent.172
The ‘153 Patent disclosure is extremely similar to the ‘167 Patent’s
disclosure.173 Titled “Method for producing sugar cane juice,” the ‘153
Patent claims a process for producing juice from sugarcane stalks.174 The
‘153 Patent process is nearly identical to the process claimed by the ‘167
Patent’s application, except it takes no steps to preserve the policosanols
in sugarcane stalks and does not even mention the compound.175 Further,
the examiner stated that despite the ‘153 Patent failing to teach a
policosanol-rich bagasse, the ‘153 Patent process “would inherently
produce policosanol-rich bagasse” because similar stalks were passed
through similar rollers in both processes.176 In conjunction with the shared
inventorship between the ‘153 Patent and the ‘167 Patent’s application,
these similarities led the examiner to make an obviousness-type double
patenting rejection.177
The obviousness rejection was supported with multiple references to
the ‘153 Patent specification.178 These references point out the nearly
identical juice extraction, filtration, heating, clarification, flocculation,
and evaporation steps between the two claimed processes.179 In the
absence of evidence to the contrary, the examiner found that the ‘167
Patent’s application as a whole was obvious to a PHOSITA in light of the
‘153 Patent.180
Mr. Gonzalez successfully rebutted both rejections with a three-part
argument focused on the preservation of policosanols.181 First, the ‘167
Patent application called for specific limitations in the sugarcane juice
production process explicitly designed to preserve policosanols.182 The
steps mentioned by Mr. Gonzalez to preserve policosanols include: (1)
not cleaning the cut cane stalks; (2) heating the pH-stabilized juice
without reaching a temperature that would evaporate policosanols; and
(3) filtering and re-adding the froth from the clarification step back into
the juice.183 Second, the ‘153 Patent discloses steps that would destroy
172. Id. at 5.
173. U.S. Patent No. 6,245,153 (filed August 8, 1999).
174. Id.
175. Id.
176. Non-Final Office Action, supra note 140, at 4.
177. Id. at 3-4.
178. Id. at 4-7.
179. Id. at 5-6.
180. Id. at 6-7.
181. U.S. Patent No. 10,632,167 (filed Nov. 3, 2017), Amendment dated Nov. 21, 2019, p. 8, 1112 [hereinafter Amendment].
182. Id. at 8.
183. Id. at 8-10.
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policosanols, including the cleaning of the cut cane stalk, excessive
heating of the juice, and removal of policosanol-rich froth.184 Lastly, Mr.
Gonzalez argued that it took “over five years of continuous research and
experimentation to arrive at a modified version of [the] original
process.”185
Ultimately, Mr. Gonzalez was successful in rebutting the examiner’s
rejections and was granted the patent.186 Because of this, the ‘167 Patent
would be given a presumption of validity if challenged in a court of law.187
However, just because a patent is presumed valid does not mean it cannot
be found invalid.188
III. DISCUSSION
Unfortunately, if the ‘167 Patent is challenged in an infringement
lawsuit in the U.S., the court would likely deem it valid. This does not
mean that Colombians should be concerned about their way of life being
upended. First, Section A of this Part breaks down why the ‘167 Patent
would likely be upheld. Second, Section B discusses why, regardless of
its validity, the ‘167 Patent would not impact the Colombian panela
industry.
A. U.S. Patent Validity
If challenged in a U.S. court of law, the ‘167 Patent’s validity would
likely be upheld. Of the main U.S. criteria for patentability, a lack of
utility presents the strongest argument for the ‘167 Patent’s invalidity.
Although they would be weak, novelty and obviousness arguments can
also be made against validity.
The strongest argument against the ‘167 Patent’s validity is for lack of
utility. Even though the utility threshold is low, all patentable inventions
must be useful.189 The issue lies with the efficacy of policosanols. As
shown through the ‘167 Patent’s prosecution history, the ‘167 Patent is
only patentable over the ‘153 Patent because of the process changes it
implements to preserve policosanols in the final juice product.190 Without
these changes, the ‘167 Patent would be unpatentable for obviousness and

184. Id.
185. Id. at 8.
186. U.S. Patent No. 10,632,167 (filed Nov. 3, 2017), Notice of Allowance dated Feb. 26, 2020, p.
1 [hereinafter Notice of Allowance].
187. MUELLER, supra note 11, at 959.
188. Id.
189. Juicy Whip, Inc. v. Orange Bang, Inc., 185 F.3d 1364, 1366 (Fed. Cir. 1999).
190. See Amendment, supra note 181, at 7-13; Notice of Allowance, supra note 186.
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double patenting.191 Because the policosanols comprise the novel and
non-obvious portion of the ‘167 Patent, it is the policosanols that must
have utility; if there is no utility in the preservation of policosanols, then
the only other utility is in producing a sugarcane juice product, a feat
already accomplished by the ‘153 Patent.192
There is little research and increased skepticism regarding the true
effects of policosanols, especially the effects boasted by the ‘167
Patent.193 According to the ‘167 Patent, policosanols are a side-effect-free
alternative to blood cholesterol pharmaceuticals such as Lipitor, Crestor,
and Lescol; it even claims that policosanols are just as, if not more,
effective than these leading brands.194 The ‘167 Patent asserts that
policosanols “are remarkably effective” in reducing a component of
cholesterol known to cause a slew of health-related problems.195 The
scientific community, however, is skeptical of policosanols’ purported
health benefits because the original results indicating that policosanols are
a miracle compound have been unrepeatable.196
This unrepeatability implies that the utility of policosanols is not yet
known. At the very least, the attempted recreations of the Cuban studies
indicate that policosanols, outside of the exact conditions and preparation
methods of those studies, have no proven utility.197 This situation can be
equated to the Brenner case.198 Like the similar steroid homologues in
Brenner, the policosanols derived by the ‘167 Patent will be of at least
similar purity levels and alcohol chain lengths as the original Cuban
policosanol supplements because of their shared sugarcane base.199 But,
as determined in Brenner, similar chemical make-ups are not a sufficient
basis for utility.200 Here, if the ‘167 Patent’s policosanols do not actually
lower cholesterol, the true utility of the sugarcane juice is left to be
discovered by someone else. Therefore, because the policosanols have no
established utility, the issued patent would be invalid.201
Unfortunately, even though there is no conclusive evidence of the ‘167
Patent’s utility, the limited studies available are unlikely to overcome the
‘167 Patent’s presumption of validity. With this presumption of validity
191. See Amendment, supra note 181, at 7-13; Notice of Allowance, supra note 186; Non-Final
Office Action, supra note 140, at 2-6.
192. U.S. Patent No. 6,245,153 (filed August 8, 1999).
193. Smith, supra note 5.
194. U.S. Patent No. 10,632,167 (filed Nov. 3, 2017).
195. U.S. Patent No. 10,632,167 (filed Nov. 3, 2017).
196. Marinangeli, supra note 139, at 259.
197. Id. at 265.
198. Brenner v. Manson, 383 U.S. 519 (1966).
199. Id. at 531-532.
200. Id. at 535.
201. 35 U.S.C. § 101 (2019).
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follows the presumption of credibility of source.202 Although current
research appears to question the credibility of Mr. Gonzalez’s assertions,
it is not the job of the patent examiners at the USPTO to conduct extensive
research into the validity of utility claims.203 Rather, the USPTO “must
treat as true a statement of fact made by an applicant in relation to an
asserted utility.”204 To overcome this presumption, a significant amount
of evidence would be necessary to prove that the original studies were so
wrong that the patent should be invalidated.205 Because this evidence
simply does not yet exist, it is unlikely that an attack on the credibility of
the underlying utility of the ‘167 Patent would be sufficient for a court to
invalidate the patent.
A second argument against the ‘167 Patent’s validity is for lack of
novelty, and in the alternative, for being obvious, over the traditional
methods of producing panela that have been practiced for centuries.206
Because of the ‘167 Patent’s narrowness and having already overcome
similar rejections during patent prosecution, this argument is likely to
fail.207 As mentioned above, the novelty standard requires prior art satisfy
the strict identity standard to anticipate the claimed invention.208
Therefore, for the ‘167 Patent to be invalidated for lack of novelty, it must
be shown that the claimed method for producing the policosanol-rich
sugarcane juice is identical to any current or former method of producing
panela.
At their core, the ‘167 Patent’s claims are made up of the following
nine steps: (1) hand-cut raw sugarcane; (2) shred the unwashed sugarcane;
(3) run the shredded sugarcane through a series of roller mills designed to
extract the sugarcane juice from the stalks; (4) filter the resulting juice;
(5) stabilize the pH of the filtered juice; (6) heat the stabilized juice; (7)
clarify the heated juice via flocculation; (8) concentrate the sugar content
via evaporation; and (9) extract the evaporated juice concentrate.209 When
comparing these steps to the traditional process used in Colombia, there
seems to be a strong case for anticipation. In both processes, sugarcane is
hand-cut, subjected to a series of rollers and a pH management step,
clarified via natural flocculants, heated, evaporated, and cooled.210
Even though there are striking similarities between these two
202. MUELLER, supra note 11, at 959.
203. Id. at 497.
204. Id.
205. Id. at 959. Although not statutorily established, the standard of proof for the invalidity of an
issued patent is “clear and convincing.” Id.
206. See supra Part II.A.
207. See supra Part II.D.3.
208. MUELLER, supra note 11, at 242.
209. U.S. Patent No. 10,632,167 (filed Nov. 3, 2017).
210. Smith, supra note 5.
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processes, the ‘167 Patent implements specific limitations within each
step.211 These specific limitations include: (1) not cleaning the cut cane
stalks; (2) heating the pH-stabilized juice without reaching a temperature
that would evaporate policosanols; and (3) filtering the froth resulting
from the use of flocculants during the clarification process and re-adding
it to the juice.212 Further, the ‘167 Patent is based on the use of industrial
technology.213 Conversely, the traditional method of panela production is
much less specific.214 For example, the proper heating temperatures and
evaporation steps of the traditional method are all performed manually
and without specific ranges.215 While it is conceivable that at some point
a Colombian trapiche has kept temperatures below seventy degrees
Celsius, the total combination of policosanol-preserving steps has likely
never been performed. Therefore, a lack of novelty argument is likely to
fail.
The final argument against the ‘167 Patent’s validity is that it would
have been obvious to a PHOSITA to produce cane juice as claimed by the
patent.216 The ‘167 Patent was originally rejected for obviousness, but the
rejection was rescinded upon further argument by Mr. Gonzalez.217 Mr.
Gonzalez was able to work around these rejections by identifying the ‘167
Patent’s additional measures to preserve policosanols and the extensive
testing performed to perfect those measures.218 Therefore, because the
obviousness arguments have already been tried and reversed, this
argument is not likely to prove invalidity.
Ultimately, for the ‘167 Patent to be ruled invalid, the most persuasive
argument is that the policosanols have no actual utility. Because the
novelty and obviousness arguments have essentially been exhausted, it is
unlikely they would prevail without the surfacing of additional relevant
prior art. Luckily for Colombians, the validity of the ‘167 Patent should
not cause alarm.
B. The Effect of U.S. Patent No. 10,632,167 on the Colombian Panela
Market
While at first glance the ‘167 Patent may appear disastrous for the
Colombian panela industry, it is unlikely to cause any changes. First, the
211. U.S. Patent No. 10,632,167 (filed Nov. 3, 2017).
212. Id.
213. Id.
214. Lopez-Alt, supra note 1.
215. See supra Part II.A.
216. See supra Part II.B.2.
217. See Non-Final Office Action, supra note 140; Amendment, supra note 181; Notice of
Allowance, supra note 186.
218. Amendment, supra note 181.
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exclusionary rights granted by a patent are limited by the geographic
borders of the country in which it was issued.219 Second, the ‘167 Patent
only prevents producers from processing sugarcane under the exact
method claimed by the patent. Third, the Colombian government is not
likely to allow a single entity to upend one of the most important
industries within its borders.
The exclusionary rights of patents are generally not enforced
extraterritorially.220 Even if the ‘167 Patent is valid in the U.S., its
exclusionary rights would not apply in Colombia unless a patent is also
granted there.221 Given that only 0.4% of Colombian panela becomes
destined for export, the 98% that is consumed domestically would be
unaffected.222
The ‘167 Patent’s claims and prosecution history reveal the impact the
patent is likely to have on the Colombian panela industry. For the ‘167
Patent to exclude panela producers, those producers would need to follow
the patent exactly.223 Because the standard method of panela production
does not incorporate the precise method detailed in the ‘167 Patent,
traditional panela producers would not be liable for infringement. First,
the panela produced in Colombian trapiches is typically a solid product,
whereas the ‘167 Patent covers the production of a liquid.224 Second, Mr.
Gonzalez did not file the ‘153 Patent in Colombia; the ‘153 Patent was a
broader version of the current patent, so Mr. Gonzalez likely knew it
would waste resources to file an application where the patent would not
be granted or, at the very least, profitable.225
Further, because the ‘167 Patent’s claims are narrow, if granted in
Colombia, they are unlikely to cover traditional panela production.
Colombian patent law does not recognize the doctrine of equivalents and
proving literal infringement of the ‘167 Patent’s narrow claims would be
a difficult task. 226 But, even if the patent is granted in Colombia and a
Colombian court somehow finds that traditional panela production
literally infringes the ‘167 Patent, the infringing producer would be able
to claim prior user rights by pointing to panela’s extensive history,
thereby avoiding sanctions.
Lastly, the Colombian government would not allow a single entity to
turn its panela industry upside down. Under Law 40, even current

219.
220.
221.
222.
223.
224.
225.
226.

MUELLER, supra note 11, at 1095-1096.
Id.
Id.
Rodriguez et al., supra note 12.
See supra Part II.C.
U.S. Patent No. 10,632,167 (filed Nov. 3, 2017).
U.S. Patent No. 6,245,153 (filed August 8, 1999).
Olarte, supra note 115, at 51.
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producers of centrifugal sugar cannot fully intrude on the panela market
when their own market becomes saturated.227 Panela producers are held
to a high standard and are strictly regulated to maintain the over 350,000
jobs that are directly and indirectly related to the industry.228 Therefore,
even if Mr. Gonzalez is somehow able to enter the market alongside
traditional trapiches, he would face strict regulations on the quantity of
product he would be able to produce and business for the traditional
trapiches would continue as usual.229
IV. CONCLUSION
In conclusion, the ‘167 Patent would likely be found valid if challenged
in a U.S. court of law. The strongest argument against its validity is that
it lacks utility because the Cuban studies that make up its basis of utility
have questionable credibility.230 If challengers to the ‘167 Patent were to
make this argument, they should produce additional studies to fully
discredit the Cuban studies and prove that policosanols have neither the
utility claimed nor any other use.231
Fortunately for Colombians, the ‘167 Patent is unlikely to have any
major impact on Colombia’s panela market regardless of whether the
patent is valid. The scope of the ‘167 Patent’s claims is narrow and would
only prevent panela producers from operating within very specific means.
Further, because only 0.4% of Colombian panela is used for export, and
because U.S. patents only prevent U.S. production and importation, the
Colombian market will be virtually unaffected by the U.S. patent.232
Colombians should therefore be unalarmed by the ‘167 Patent and its
Colombian counterpart and continue to enjoy the regional delicacy.

227. L. 40, diciembre 4, 1990, DIARIO OFICIAL [D.O.] (Colom.).
228. Rodriguez et al., supra note 12.
229. See supra Part II.A.
230. MPEP (9th ed., June 2020) § 2107(II)(A)(3).
231. If another use is found between now and the time the studies are sufficiently discredited, then
new use will stand to meet the utility requirement. MUELLER, supra note 11, at 497.
232. Rodriguez et al., supra note 12.
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